|
Γενετικά Τροποποιημένοι Οργανισμοί: Όχι από το Συμβούλιο
Το Συμβούλιο των Υπουργών Περιβάλλοντος καταψήφισε και τις 8
προτάσεις
της Επιτροπής σχετικά με τους Γενετικά Τροποποιημένους
Οργανισμούς.
Περισσότερα (ΕΝ)...
Brussels/Luxembourg, 24 June 2005
GMOs: Commission reaction on Council
votes on safeguards and GM maize MON863
The Environment Council voted today on a
package of proposals from the Commission concerning
genetically modified organisms (GMOs). The proposals require
the lifting of bans or restrictions (so-called national
safeguard clauses) imposed by Austria, France, Germany,
Greece and Luxembourg on 8 authorised GM products. The
Council voted against all 8 Commission proposals. This is
the first time that Council found a qualified majority
against a Commission proposal on GMOs. It is thus a new
situation in terms of subsequent action. The Commission will
have to carefully consider the legal and scientific bases
that underpin any further proposals, as well as the
implications for EU internal market and trading partners. In
a separate proposal involving the authorisation of placing
MON863 maize on the European market for import, processing
and feed use, the Council did not find the required
qualified majority for or against. This case will now go
back to the Commission for a final decision.
Stavros Dimas, Commissioner for the
Environment, said, "The Commission has a legal obligation to
make sure that the existing regulatory framework governing
the release of GMOs is correctly applied by Member States.
That is why we proposed to lift the current bans or
restrictions on certain GMOs in Austria, France, Germany,
Greece and Luxemburg. The fact that the Council rejected all
8 proposals raises a host of questions. What is certain is
that today’s vote sends a political signal that Member
States may want to revisit some aspects of the existing
system.”
The Commission now has three options: to
re-submit the existing proposals back to the Council, to
amend the proposals and submit to the Council, or to present
a legislative proposal on the basis of the Treaty.
Commissioner Dimas said that the Commission will now reflect
on all legal and scientific aspects related to the 8
decisions in order to decide on the best way forward.
Background on safeguard clauses
The proposals to lift the so-called
“national safeguard measures” on certain authorised
genetically modified organisms concern the GM maize
varieties T25 and MON810 banned in Austria, GM maize Bt176
banned in Austria, Germany and Luxembourg, the oilseed rape
varieties MS1xRF1 banned in France and Topas 19/2 banned in
France and Greece (see table in annex).
A number of these eight safeguard clauses
include bans or restrictions on cultivation whilst others
include bans on import and use in food and feed. The
responsible Scientific Committees deemed that the
information submitted by the Member States as justification
for the bans did not change the original risk assessments
which had been carried out as part of the authorisation
process.
In December 2003, then Environment
Commissioner Margot Wallström submitted letters to the above
Member States requesting that they re-consider their
safeguard clauses in view of the new regulatory framework
and if necessary, to re-submit them under Article 23 of
Directive 200/18/EC on the deliberate release of GMOs in the
environment (which replaced Directive 90/220/EEC). In view
of this request, Greece and Austria submitted, in the first
quarter of 2004, further information in support of their
bans but no response was received from the other Member
States.
This additional information potentially
impacted on all eight cases and was submitted to EFSA for
opinion. In its opinion of July 2004, EFSA concluded, as for
all previous arguments and information, that the additional
information did not invalidate the original risk assessments
for the GMOs in question. Consequently, the Commission was
required to submit draft decisions, initially to the
Regulatory Committee, requesting the Member States concerned
to lift their national safeguard measures.
The Regulatory Committee composed of
Member States representatives, on 29 November 2004, failed
to reach qualified majority either in favour or against any
of these draft decisions. Draft proposals were subsequently
transmitted, on 26/27 April 2005, to the Council for
opinion.
Background on MON 863
A request to market a genetically
modified maize product (line MON863), with resistance to
corn rootworm, was submitted by Monsanto to the competent
authority of Germany for assessment. The requested uses of
the product included import, processing and feed use but not
use in food or for cultivation.
The German competent authority concluded
that there was no scientific evidence that indicated any
risk for human health or the environment for the requested
uses. However, other Member States raised and maintained
objections in terms of molecular characterisation,
allergenicity, toxicity, an inadequate monitoring plan,
accidental spillage, presence of an antibiotic resistance
marker gene and detectability. The European Food Safety
Authority (EFSA) was consulted and delivered its opinion on
16 April 2004 concluding that the MON863 maize was as safe
as conventional oilseed rape and unlikely to produce adverse
effects.
Consequently, a draft Commission Decision
to place the product on the market was presented to the
Regulatory Committee for vote on 20 September 2004. However,
on 17 September 2004, the German competent authority
submitted to the Commission and to the Member States,
a re-evaluation of a rat-feeding study included in the
original application.
Many Member States expressed concerns in
terms of reaching a formal position in the Regulatory
Committee meeting, pending an examination of this
re-evaluation and consequently, no formal vote took place at
this time. Following the meeting, EFSA was requested to
evaluate the impact of the conclusions of the re-evaluated
rat study on the original risk assessment concluded that it
did not put into question its initial opinion on this
product.
The Regulatory Committee was re-convened
on 29 November 2004. The Committee, acting by qualified
majority, did not deliver an opinion. The Commission
consequently submitted a draft Proposal to the Council.
Further information on the regulation on
GMOs in the European Union can be found at:
MEMO/05/104
|
Member State
and date of invocation |
Product
details and date of Scientific Opinion concerning
original information to justify bans |
Justification for bans |
Additional
information and date of reception |
|
1. FR (20.11.98) |
Swede rape resistant to glufosinate
MS1/RF1
Uses: cultivation for breeding activities (seed
production)
Product approval: 1996
Scientific Committee Opinion: 18.05.99 |
Negative effects on human health, the
environment and agriculture;
Clarification issues re dissemination, volunteers, gene
flow and accumulation of resistance genes |
FR:
16.02.04 (holding reply); 27.08.04
renewal of prohibition until 17.10.06 |
|
2. AU (14.02.97)
3. LX (17.03.97)
4. DE (28.02.00) |
Bt-maize tolerant to glufosinate ammonium
(Bt-176)
Uses: All uses (cultivation, food and feed, processing)
Product approval: 1997
Scientif.
Committees Opinion:
21.03., 10.04., 12.05.97 (AU); 09.11.00 (DE)
EFSA: 08.07.04 (AU) |
Effects of BT-toxins on non-target
organisms and development of resistance to toxins by
target organisms
Risks associated with ampicillin antibiotic resistance
market gene |
AU:
09.01, 09.02, 17.02.04
Information concerning potential environmental impact of
Bt-toxin and allergenic and toxicological risk
assessment
LUX: 19.05.2004
Information concerning potential environmental impact of
Bt-toxin and antibiotic resistance genes as well as
allergenic and toxicological risk assessment |
|
5. EL (05.11.98)
6. FR (20.11.98) |
Swede rape tolerant to glufosinate (Topas
19/2)
Uses: import, storage and processing (no cultivation)
Product approval: 1998
Scientific Committee Opinion: 18.05.99
EFSA: 08.07.04 (EL) |
Issues concerning dissemination,
persistence, volunteers and gene flow in the environment
(arising from spillage or unintended release) |
FR:
16.02.04 (holding reply); 27.08.04 renewal of
prohibition until 17.10.06
EL: 05.03.04
Information concerning environmental risks, consu-mer
protection and co-existence (out-crossing with wild
relatives, which are consumed by humans in Greece;
enhanced capability of rape, wild relatives and hybrids
to survive/spread, potential for multi-resistant wild
plants and weeds) |
|
7. AU (01.06.99) |
Maize expressing the Bt cryIA(b)
gene (MON 810)
Uses: All uses (cultivation, food and feed, processing)
Product approval: 1998
Scientific Committee Opinion: 24.09.99
EFSA: 08.07.04 |
Effects of BT-toxins on non-target
organisms and development of resistance to toxins by
target organisms |
AU:
09.01, 09.02, 17.02.04
Information concerning potential environmental impact of
Bt-toxin and allergenic and toxicological risk
assessment |
|
8. AU (08.05.00) |
Maize tolerant to glufosinate (T25)
Uses: All uses (cultivation, food and feed, processing)
Product approval: 1998
Scientific Committee Opinion: 30.11.00 (AU)
replaced 20.07.01
EFSA: 08.07.04 |
Risk of out-crossing with wild relatives
and conventional crops as well as in sensitive areas
No monitoring
|
AU:
09.01., 09.02., 17.02.04
Information concerning allergenic and toxicological risk
assessment. |
|